Built from Within: How Local Capital Shapes Global Biotech Hubs
Biotech may be global in ambition, but ecosystems thrive when capital arrives and stays.
This is Signal. The new voice for next generation biotech leaders, presented by Nucleate.
Get the email newsletter and unlock access to members-only content and updates
Processing your application
Please check your inbox and click the link to confirm your subscription.
There was an error sending the email
Get started with our best stories
Reinventing R&D: collaborating for tomorrow’s therapies | Dr. Uli Stilz, Bio Innovation Hub at Novo Nordisk
A conversation with Dr. Uli Stilz, Head of Bio Innovation Hub at Novo Nordisk.
Breaking Barriers in Women's Health: The Vagina Business
A conversation with Dr. Marina Gerner, journalist and author of The Vagina Business
Ecosystems of Innovation: Finding Entrepreneurial Academics in the US
Explore how to identify entrepreneurial academics in biotech using key metrics like startup leadership, patents, and research grants.
Biotech journalism & scaling new heights for a good cause
A conversation with Luke Timmerman, award-winning biotech journalist and founder of the Timmerman Report.
Navigating the Biotech VC Landscape in Chicago
This report highlights the leading biotechnology venture capitalists in the Chicagoland area and provides an overview of its biotech investment landscape.
Biotech Venture Capital Activity in Brazil
Brazilian VC funding in biotech is on the rise, with approximately 50 firms investing in a diverse range of biotech sectors.
Enter the World of Hidden Layers
Introduction to the Nucleate Biotech Ecosystem Insights Series.
Introducing Signal
The human story of biotechnology, and how it will change life as we know it.
Enter the World of Hidden Layers
Introduction to the Nucleate Biotech Ecosystem Insights Series.
Generative AI will rapidly accelerate drug development
A conversation with Sean McClain, co-founder and CEO and co-founder of Absci.
Pioneering Cell Therapy
A conversation with Professor Bobby Gaspar, the CEO of Orchard Therapeutics.
In vitro Gametogenesis: The Next Frontier in Human Health Biotechnology
IVG uses stem cells to create gametes, offering a biotech breakthrough for infertility and reproductive options.
Novel CRISPR Systems
A conversation with Trevor Martin, Co-founder and CEO of Mammoth Bio.
Building the next great biotech ecosystem
A conversation with Tony Kulesa, Principal of Pillar VC and Co-Founder of Petri.
Recommended
